BHP launches Seed Fund to invest in innovation
Today (20 June) Birmingham Health Partners officially launches its BHP Seed Fund – a new initiative which will kick-start innovation by providing researchers with up to £100,000 initial investment….
‘Cellular brake’ offers clue to autoimmune response during immunotherapy
A ‘cellular brake’ which could prevent lung cancer patients from developing a dangerous autoimmune response during treatment has been identified by scientists.
The finding, published in Nature C…
The BHP Starter Fellowship – Shaun’s story
Shaun Thein is a Clinical Research Fellow in Respiratory Medicine at the University of Birmingham, and undertook his BHP Starter Fellowship between November 2020 and November 2021. He’s current…
Identifying DNA repair genes holds promise for improving cancer treatment
A new way in which cancer cells can repair DNA damage has been discovered by researchers at BHP founder-member the University of Birmingham.
These new findings shed new light on how cancer cells…
New research collaboration will develop precision cell therapies for blood disorders
The Universities of Birmingham and Oxford are to take part in one of five NHS Blood and Transplant (NHSBT) research units launched today.
The £20m programme, co-funded by the National Institute …
BHP welcomes new Professor of Regenerative Medicine
Professor Ivan Wall has been appointed as Professor of Regenerative Medicine with the Institute of Immunology and Immunotherapy at BHP founder-member the University of Birmingham.
Professor Wall…